Pricing Log in Create free account

Microbot Medical Inc. (MBOT) vs Stereotaxis Inc. (STXS)

Microbot Medical Inc. and Stereotaxis Inc. are both Medical Instruments & Supplies companies. Stereotaxis Inc. is the larger, with a market value of $105.2M against $63.8M — 1.6× the size. Stereotaxis Inc. grew revenue faster over the last twelve months: −5.46% against −59.1%. Stereotaxis Inc. has the higher net margin (−78.5% vs −3,955.2%) and the higher return on invested capital (−203.6% vs −850.5%). Across the 17 metrics below, Stereotaxis Inc. leads on 11 and Microbot Medical Inc. on 6.

Valuation

Metric MBOT STXS Medical Instruments & Supplies median
P/E n/m n/m 33.75
P/S 154.46 3.36 2.52
P/B 0.93 8.25 2.48
Price to free cash flow n/m n/m 25.19
EV/EBITDA 0.06 n/m 14.62
EV/Sales (2.87) 3.12 2.88
Earnings yield (25.26%) (23.76%) (2.67%)
Free cash flow yield (28.10%) (15.34%) 0.09%

Profitability

Metric MBOT STXS Medical Instruments & Supplies median
Gross margin (166.30%) 55.57% 54.29%
Operating margin (4,480.03%) (75.68%) 1.07%
Net margin (3,955.22%) (78.45%) (1.61%)
Free cash flow margin (4,340.11%) (51.56%) 1.08%
Return on equity (32.91%) (344.36%) (1.32%)
Return on assets (30.68%) (48.76%) 0.00%
Return on invested capital (850.51%) (203.58%) 0.00%

Growth

Metric MBOT STXS Medical Instruments & Supplies median
Revenue growth (TTM) (59.09%) (5.46%) 8.85%
EPS growth (last fiscal year) 60.27% 16.67% 8.65%
Revenue growth, 5-year CAGR 0.39% 3.99% 9.17%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric MBOT STXS Medical Instruments & Supplies median
Debt to equity 0.00 0.00 0.10
Current ratio 18.56 1.42 2.48
Net debt to EBITDA 5.35 0.65 0.89

Dividend

Metric MBOT STXS Medical Instruments & Supplies median
Dividend yield — — 1.11%
Payout ratio — — 0.27

Size

Metric MBOT STXS Medical Instruments & Supplies median
Market cap 63.80m 105.21m 619.84m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack